Emily L. Sammons - Publications

Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial.

Journal: Health technology assessment (Winchester, England)

Published: May 12, 2026

Effects of aspirin and omega-3 fatty acids on age-related macular degeneration in ASCEND-Eye: a randomised placebo-controlled trial in a population with diabetes.

Journal: BMJ open

Published: February 26, 2025

Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: October 29, 2024

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

Journal: The New England journal of medicine

Published: October 25, 2024

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 15, 2024

Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 04, 2024